The analysis revealed a significant upregulation of ESR1 expression in breast cancer tissues compared to their non-tumoral counterparts (Figure 7A), whereas GADD45A exhibited a contrasting downregulation in tumoral tissues (Figure 7C). This evidence concerns the gene ESR1 and breast carcinoma.